Episode 341: PREMIUM - Evolocumab and what it does to cardiovascular outcomes

In episode 341, James and Mike talk about the long awaited trial of evolocumab that evaluated the impact it has on cardiovascular outcomes. Certainly not a homerun - maybe a very expensive full swing bunt with an error that leads to a single. 

Show notes

1) Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease 


The full content of this Podcast, including the audio file, is available to Premium Members only. Click to find out the benefits of having a Premium Membership.

Why Get A Premium Membership ?